360 related articles for article (PubMed ID: 17852158)
41. Prevalence and risk factors for anabolic-androgenic steroid abuse among Jordanian collegiate students and athletes.
Tahtamouni LH; Mustafa NH; Alfaouri AA; Hassan IM; Abdalla MY; Yasin SR
Eur J Public Health; 2008 Dec; 18(6):661-5. PubMed ID: 18603598
[TBL] [Abstract][Full Text] [Related]
42. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
[No Abstract] [Full Text] [Related]
43. Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.
Deshmukh N; Petróczi A; Barker J; Székely AD; Hussain I; Naughton DP
Subst Abuse Treat Prev Policy; 2010 Apr; 5():7. PubMed ID: 20429943
[TBL] [Abstract][Full Text] [Related]
44. [Liver pathology associated with anabolic androgenic steroids].
Søe KL; Søe M; Gluud CN
Ugeskr Laeger; 1994 Apr; 156(17):2585-8. PubMed ID: 8016966
[TBL] [Abstract][Full Text] [Related]
45. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids.
Robles-Diaz M; Gonzalez-Jimenez A; Medina-Caliz I; Stephens C; García-Cortes M; García-Muñoz B; Ortega-Alonso A; Blanco-Reina E; Gonzalez-Grande R; Jimenez-Perez M; Rendón P; Navarro JM; Gines P; Prieto M; Garcia-Eliz M; Bessone F; Brahm JR; Paraná R; Lucena MI; Andrade RJ; ;
Aliment Pharmacol Ther; 2015 Jan; 41(1):116-25. PubMed ID: 25394890
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
[TBL] [Abstract][Full Text] [Related]
47. Assessment of Anabolic Androgenic Steroids Use Among Professional CrossFit
Lima PMA; Barros YC; Barros ABN; Farias LM
Subst Use Misuse; 2024; 59(10):1488-1494. PubMed ID: 38812099
[TBL] [Abstract][Full Text] [Related]
48. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases.
Montisci M; El Mazloum R; Cecchetto G; Terranova C; Ferrara SD; Thiene G; Basso C
Forensic Sci Int; 2012 Apr; 217(1-3):e13-8. PubMed ID: 22047750
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of aminotransferase elevations in a bodybuilder using anabolic steroids: hepatitis or rhabdomyolysis?
Pertusi R; Dickerman RD; McConathy WJ
J Am Osteopath Assoc; 2001 Jul; 101(7):391-4. PubMed ID: 11476029
[TBL] [Abstract][Full Text] [Related]
50. Predicting future anabolic-androgenic steroid use intentions with current substance use: findings from an internet-based survey.
Dunn M; Mazanov J; Sitharthan G
Clin J Sport Med; 2009 May; 19(3):222-7. PubMed ID: 19423975
[TBL] [Abstract][Full Text] [Related]
51. Early Left Ventricular Diastolic Dysfunction, Reduced Baroreflex Sensitivity, and Cardiac Autonomic Imbalance in Anabolic-Androgenic Steroid Users.
Kouidi EJ; Kaltsatou A; Anifanti MA; Deligiannis AP
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34209901
[TBL] [Abstract][Full Text] [Related]
52. Androgenic-anabolic steroids abuse in males.
Di Luigi L; Romanelli F; Lenzi A
J Endocrinol Invest; 2005; 28(3 Suppl):81-4. PubMed ID: 16042364
[TBL] [Abstract][Full Text] [Related]
53. Aggression and body image concerns among anabolic androgenic steroid users, contemplators, and controls in Norway.
Jenssen IH; Johannessen KB
Body Image; 2015 Jan; 12():6-13. PubMed ID: 25261635
[TBL] [Abstract][Full Text] [Related]
54. Current concepts in anabolic-androgenic steroids.
Evans NA
Am J Sports Med; 2004 Mar; 32(2):534-42. PubMed ID: 14977687
[TBL] [Abstract][Full Text] [Related]
55. Impact of androgenic anabolic steroid use on cardiovascular and mental health in Danish recreational athletes: protocol for a nationwide cross-sectional cohort study as a part of the Fitness Doping in Denmark (FIDO-DK) study.
Buhl LF; Lehmann Christensen L; Diederichsen A; Lindholt JS; Kistorp CM; Glintborg D; Andersen M; Frystyk J
BMJ Open; 2024 May; 14(5):e078558. PubMed ID: 38719280
[TBL] [Abstract][Full Text] [Related]
56. Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes.
Fyksen TS; Vanberg P; Gjesdal K; von Lueder TG; Bjørnerheim R; Steine K; Atar D; Halvorsen S
Scand J Med Sci Sports; 2022 Aug; 32(8):1170-1181. PubMed ID: 35460300
[TBL] [Abstract][Full Text] [Related]
57. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
58. Anabolic-androgenic steroids (AAS) users on AAS use: Negative effects, 'code of silence', and implications for forensic and medical professionals.
Richardson A; Antonopoulos GA
J Forensic Leg Med; 2019 Nov; 68():101871. PubMed ID: 31557629
[TBL] [Abstract][Full Text] [Related]
59. National Athletic Trainers' Association position statement: anabolic-androgenic steroids.
Kersey RD; Elliot DL; Goldberg L; Kanayama G; Leone JE; Pavlovich M; Pope HG;
J Athl Train; 2012; 47(5):567-88. PubMed ID: 23068595
[TBL] [Abstract][Full Text] [Related]
60. The effects of anabolic androgenic steroid abuse on gingival tissues.
Ozcelik O; Haytac MC; Seydaoglu G
J Periodontol; 2006 Jul; 77(7):1104-9. PubMed ID: 16805671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
